Applications

1196.2 – Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression (resubmission)

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type Re-application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Partially supported

Application details

Reason for application

Re-submission.

Service or technology in this application

Repetitive Transcranial Magnetic Stimulation (rTMS) is a focal brain stimulation treatment. Small electrical currents that pass through an electromagnetic coil held near the patient’s scalp stimulate nerve cells in the region of the brain involved in mood regulation and depression (motor cortex). rTMS does not require an anaesthetic and there is no associated cognitive impairment or other serious side effects.

Type: Therapeutic

Medical condition this application addresses

Major Depression (DSM IV) is a disorder of mood with features of depressed mood, loss of energy and interest, loss of pleasure, feelings of hopelessness and worthlessness, sleep and appetite disturbance and suicidal thoughts and behavior. Accompanying disability can be severe and lead to social and occupational disruption.

There are a range of different treatments available to treat major depressive disorders, including medication and psychological treatments. However, 10% to 30% of patients with major depression do not respond to antidepressant medication.

Previous applications

1196.1 – Repetitive Trans cranial Magnetic Stimulation (rTMS) for the treatment of depression (resubmission)
1196 – Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression

Application documents

Public summary document

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Consultation survey and deadlines

Feedback and comments are welcome at any stage during the MSAC process. Please provide comments on Application 1196.2 via a of two A4 pages to (making sure that you type the application number at the start of your comments in the subject heading of your email).--
-13 June 20191-2 August 2019

Meetings to consider this application

  • PASC meeting: -
  • ESC meeting: 13 June 2019
  • MSAC meeting: 1-2 August 2019